伟德官网手机版附屬金陵醫院内分泌科主任，主任醫師、教授，日本順天堂大學内分泌博士。江蘇省科教興衛醫學重點人才。國家自然科學基金國際合作項目評審專家。2005年獲衛生部笹川獎學金公派至日本東京順天堂大學留學，2015年獲得中華醫學會糖尿病分會獎學金赴英國謝菲爾德大學皇家Hallamshire醫院進修。臨床和科研專長為糖尿病、代謝綜合征、垂體疾病、痛風與高尿酸血症的診治。

中國微循環學會糖尿病與微循環分會青委會主任委員，中國神經科學學會神經内穩态和内分泌分會常委，江蘇省醫學會内分泌學分會副主任委員、江蘇省醫學會糖尿病學分會常委。World Journal of Diabetes、中華糖尿病雜志編委。

1. Yanyu   Yuan, Bin Lu, Qingyu Guo, Wei Wang, Zhouqin Feng, Xuguang Jin, Hui Zhou, Jun   Liu, Haiyan Lei, Xinyi Yang, Jun Liu, Yanyu Liu, Jiaqing Shao(通訊作者), Ping Gu.Time in range, as an   emerging metric of glycemic control, is associated with orthostatic blood   pressure changes in type 2 diabetes. Diabetes Res Clin Pract,2022   Jan;183:109179

2. Chen   T, Zhang Z, Lei H, Fen Z, Yuan Y, Jin X, Zhou H, Liu J, Wang W, Guo Q, Li L,   Shao J(通訊作者). The   relationship between serum 25-hydroxyvitamin-D level and sweat function in   patients with type 2 diabetes mellitus. J Endocrinol Invest. 2022   Feb;45(2):361-368.

3. Feng   ZQ, Guo QY, Wang W, Yuan YY, Jin XG, Zhou H, Liu J, Lei HY, Yang XY, Liu J,   Lu B, Shao JQ(通訊作者), Gu   P. Time in range, especially overnight time in range, is associated with   sudomotor dysfunction in patients with type 1 diabetes. Diabetol Metab Syndr.   2021 Oct 26;13(1):119

4. Li   X, Zhou L, Zhang Y, He X, Lu H, Zhang L, Tian Y, Liu X, Zheng H, Shao J(通訊作者), Long M. mGPDH Deficiency leads   to melanoma metastasis via induced NRF2. J Cell Mol Med. 2021   Jun;25(11):5305-5315

5. Xu   SY, KeLi, Zhang Z, Liu CY, Guo QY, Lu B, Gu P, Shao JQ(通訊作者). Association between time in   range, a novel measurement of glycemic control and islet secretory function   in chinese patients with type 2 diabetes mellitus-An observational study.   Diabetes Res Clin Pract. 2021,Feb 1;173:108684.

6. Chen   J, Wang W, Guo Z, Huang S, Lei H, Zang P, Lu B, Shao J(通訊作者), Gu P. Associations between gut   microbiota and thyroidal function status in Chinese patients with Graves'   disease. J Endocrinol Invest. 2021 Jan 22. doi: 10.1007/s40618-021 -01507-6.   Epub ahead of print.

7. Qing-Yu   Guo, Bin Lu, Zhan-Hong Guo, Zhou-Qin Feng, Yan-Yu Yuan, Xu-Guang Jin, Pu   Zang, Ping Gu, Jia-Qing Shao(通訊作者). Continuous glucose monitoring defined time-in-range is   associated with sudomotor dysfunction in type 2 diabetes. World J Diabetes,2020   (11): 489-500

8. Jing   Liang J, Liu J, Chen Y, Ye B, Li N, Wang X, Tang M, Shao J(通訊作者). Characteristics of laboratory   findings of COVID-19 patients with comorbid diabetes mellitus. Diabetes Res   Clin Pract. 2020 Jul 22;167:108351.

9.Qingyu Guo, Pu   Zang, Shaoying Xu, Wenjing Song,Zhen Zhang, Chunyan Liu,  Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu,   Jiaqing Shao（通訊作者）. Time   in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with   Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c   in Chinese Type 2 Diabetes. Journal of Diabetes Research, vol.2020, Article   ID 5817074, 11 pages

10. Bai-lu   Cao, Yue Yao, Yi-xin Xu, Jiang Fang, Wen-jing Song, Bin Hu, Qing-yu Guo, Bin   Lu, Jie Li, Ping Gu,Jia-qing Shao（通訊作者）. The Relationship Between β-cell Function   Indices and Sudomotor Function in Chinese Patients with Type 2 Diabetes. Exp   Clin Endocrinol Diabetes (experimental and clinical endocrinology &   diabetes), Exp Clin Endocrinol Diabetes. 2021 Aug;129(8):553-559.

11. Ping   Gu, Wei Wang, Yue Yao, Yixin Xu, Liping Wang, Pu Zang, Jian Ma, Cuihua Yang,   Junya Liang, Bin Lu, Jiaqing Shao（通訊作者）.Increased Circulating Chemerin in Relation to Chronic   Microvascular Complications in Patients with Type 2 Diabetes. International   Journal of Endocrinology, Volume 2019, Article ID 8693516, 11 pages

12. Li   K,Song WJ,Wu X,Gu DY,Zang P,Gu P,Lu B,Shao JQ（通訊作者）. Associations of serum glucagon levels with   glycemic variability in type 1 diabetes with different disease durations.   Endocrine. 2018 Sep;61(3):473-481.

1、國家自然科學基金：大黃酸激活SIRT1信号通路對胰島α細胞的作用及機制研究(81873174) , 55萬，2019-2022，第一完成人

2、國家自然科學基金：選擇性阻斷胰島局部RAS 對α細胞胰高血糖素分泌功能的調控作用及機制研究, 70萬，2015-2018，第一完成人

3、國家自然科學基金：選擇性阻斷新發現的胰島局部RAS對β細胞自身胰島素抵抗及分泌功能的影響, 19萬，2009-2011，第一完成人

1、中國人民解放軍醫療成果三等獎：代謝綜合征相關危險因素分析及早期幹預。第1完成人。

2、江蘇醫學科技二等獎: 新型脂肪因子Chemerin在代謝性疾病及相關并發症風險評估中的作用第3完成人。